Health officials have urgently recalled thousands of bottles of a hair serum over a risk of 'serious injury or death.'
The US Consumer Product Safety Commission (CPSC) announced Thursday that 27,400 spray bottles of Tomum Hair Regrowth Treatment with Minoxidil for Men and Women have been recalled because the bottles do not have child-resistant packaging.
The Poison Prevention Packaging Act of 1970 requires products containing minoxidil - a hair growth medication - to have child-resistant packaging due to a risk of extreme drops in blood pressure and increases in heart rate if even small amounts are ingested.
'The hair serum's bottles are not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children,' CPSC said.
No injuries or adverse effects related to the recall have been reported to date.
The affected products were sold in 100mL bottles on Amazon from March 2025 through September 2025 for about $20 and were distributed by Belleka Inc of China.
The spray bottles are silver with a blue wraparound label and black cap. They are packaged in a blue box and both the bottle and box have 'TOMUM' and 'Hair Growth Treatment' printed on labels located on their fronts.
CPSC has urged consumers to 'secure the recalled serum bottles out of sight and reach of children immediately and contact Belleka for a free replacement product including two child-resistant bottles of serum (60 mL per unit).'
The agency also noted consumers will be asked to dispose of the recalled product bottle and send a photo of the bottle in the trash to Belleka at tomumcs@gmail.com.
Consumers with questions can email Belleka, call 862-244-1785 or contact the company through its website.
There are no publicly reported fatalities in the US to date among young children who accidentally consumed minoxidil.
Minoxidil has exploded in popularity in recent years, alongside hair loss drug finasteride, with about 13 million Americans estimated to use the drug in 2024.
The US hair loss market has also surged in value, with estimates suggesting it will more than double from a value of $2.8 billion to more than $5.3 billion over the next decade.
Minoxidil works by boosting blood flow to the areas surrounding hair follicles, which can stimulate hair regrowth and restore hair in previously bald patches.
It's formulated in low concentrations in hair loss treatments to achieve this effect safely, minimizing the risk to patients.
If consumed, doctors treat patients by administering large amounts of fluids and medications to raise blood pressure.
The FDA has only approved minoxidil as a drug for treating hair loss. Minoxidil is also sold in the US under brand name Rogaine.
There have been several other recent recalls of hair products containing minoxidil.
In August 2025, Sefralls Minoxidil Hair Generation Serum, sold in amber dropper bottles for $10 on Amazon, was recalled due to not being in child-resistant packaging. No injuries or deaths have been reported to date.
Additionally, a recall was issued last July for Aemerry Hair Growth Serums, which also was not sold in child-safe bottles.